![David W. Pritchard](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David W. Pritchard
Plus aucun poste en cours
Profil
David W.
Pritchard served as President, Chief Executive Officer & Director at Humanigen, Inc. from 2006 to 2014.
Prior to that, he was the Chief Financial Officer & VP-Business Development at CymaBay Therapeutics, Inc. from 1992 to 2000.
He also held positions at Matrix Pharmaceutical, Inc. and Rinat Neuroscience Corp.
as Chief Financial Officer and Chief Business Officer, respectively.
Additionally, he worked as a Principal at Triton Biosciences, Inc. Pritchard holds an MBA from Stanford University and an undergraduate degree from Cornell University.
Anciens postes connus de David W. Pritchard
| Sociétés | Poste | Fin |
|---|---|---|
| HUMANIGEN, INC. | Directeur Général | 08/01/2014 |
| CYMABAY THERAPEUTICS, INC. | Directeur Financier/CFO | 01/01/2000 |
Triton Biosciences, Inc. | Corporate Officer/Principal | - |
Matrix Pharmaceutical, Inc.
 Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Researches and develops pharmaceutical products | Directeur Financier/CFO | - |
Rinat Neuroscience Corp.
 Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Corporate Officer/Principal | - |
Formation de David W. Pritchard
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
18
Relations au 1er degré
7
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Researches and develops pharmaceutical products | Health Technology |
CymaBay Therapeutics, Inc.
 CymaBay Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for people with life-threatening diseases | Health Technology |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Manufactures & markets drugs for treating neurological diseases | Health Technology |
Triton Biosciences, Inc. |
